All Infection Prevention & Control articles – Page 5
-
NewsResearchers discover new mosquito-specific viruses
A new study looked at mosquitoes’ immune response to discover many more insect viruses. Researchers hope to someday use the mosquitoes’ own immune system to battle some of the most pervasive and antagonistic human viruses.
-
NewsNew cellular target prevents hepatitis E infection
To replicate, a virus must first enter a host cell. In a recent study, the researchers specifically investigated host cell processes required for successful HEV infection. In doing so, they identified the enzyme PIKfyve as a crucial factor for viral entry.
-
NewsImmune cells in the nose slow influenza virus
Memory cells in the nose slow the influenza virus as soon as it enters the body. They reduce viral levels and may help protect against more severe illness, according to a study that may help guide the development of better influenza vaccines.
-
NewsSeparating signal from noise: How African biostatisticians are reshaping the fight against malaria
Biostatistics is unlocking smarter malaria solutions, linking parasite diversity, vaccines, and human behaviour to drive more effective prevention and protection.
-
NewsA universal toolkit for editing bacterial DNA
A major collaboration involving nine labs has transferred a particularly useful DNA editing system from E. coli into 14 new species of bacteria, spanning three major branches of the bacterial family tree.
-
NewsGut microbiota impacts resistance to bacterial pneumonia: Study
A gut-lung connection influences susceptibility to infection by Acinetobacter baumannii, according to a new study. Investigators found that antibiotics disrupt the gut microbiota, suppress protective immune system pathways in the lungs; and increase the severity of pneumonia.
-
NewsResearchers develop promising new vaccine against H5N1 bird flu
Researchers have developed a vaccine approach that shows promise in protecting against highly pathogenic bird flu, demonstrating strong efficacy in both mice and cattle. In 2024, the virus spread to dairy cattle and subsequently caused illness in about 70 farm workers with close contact to infected animals.
-
NewsAmbient air pollution is associated with respiratory infection burden in the first year of life
Ambient air pollution is associated with respiratory infection burden in the first year of life, according to preliminary findings from the Immune Development in Early Life (IDEaL) Rome Cohort.
-
NewsDetailed map of life-threatening Vibrio bacteria reveals new target for treatment
Scientists have mapped in unprecedented detail the structure of Vibrio bacteria, which can cause life-threatening infections linked to antibiotic resistance. The team behind the study say the finding could provide new targets for life-saving treatment.
-
NewsComputational approach takes the guesswork out of drug development for Chagas disease
Researchers have established a computational protocol that could accelerate the development of more effective treatments for life-threatening parasitic infections such as Chagas disease, by enabling scientists to accurately identify reactions that can result in successful drug candidates without the need for trial and error.
-
NewsCinnamic acid blocks plasmid conjugation to slow antibiotic resistance spread
A new study reveals that cinnamic acid, a widely used food additive found in cinnamon, can effectively inhibit plasmid‑mediated conjugation, a major route for the global spread of antibiotic resistance genes (ARGs).
-
NewsNew study examines measles vaccination coverage after a postelimination outbreak
In 2022–2023, a large postelimination measles outbreak occurred in central Ohio. A study found that 20 months after the outbreak, MMR coverage across the entire primary care network (PCN) population remained well below herd immunity levels, with minimal gains.
-
NewsEight-year results from two randomized phase 3 trials of tenofovir alafenamide for chronic hepatitis B virus infection in China
Tenofovir alafenamide (TAF) has demonstrated comparable efficacy to tenofovir disoproxil fumarate (TDF), with improved renal and bone safety, in Chinese participants with chronic hepatitis B enrolled in two Phase 3 trials.
-
OpinionReversing the threat: How to stop measles from spreading again
As the Global Virus Network issues a stark warning over the significant resurgence of measles in the US and globally, William J. Moss, Sten H. Vermund, and Maggie L. Bartlett set out what needs to be done if the preventable harms of the current surge are to be reversed.
-
NewsCOVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.
-
NewsScientists catch a fungal enzyme open for business
A new study shows that caspofungin, a widely used antifungal drug, works only when its target enzyme is active, pointing the way toward designing better treatments.
-
NewsResearch on tick-transmitted disease reveals potential weakness, opening paths to new treatments
Tularemia is a rare but highly infectious disease caused by Francisella tularensis, a bacterium that can evade immune defenses. Scientists have isolated and studied a set of proteins that play a central role in infection, revealing a potential weakness.
-
NewsNew clues to hepatitis B species restriction could help build a novel model for studying infection and testing therapies
For decades, it was thought that the barrier to creating a workable mouse model for hepatitis B is an inability for the virus to gain a genetic foothold in the mouse due to its unique type of DNA. Now researchers have discovered that the problem is something different altogether—likely a misstep in the entry process.
-
NewsWHO certifies the Bahamas for eliminating mother-to-child transmission of HIV
In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.
-
NewsNasal spray could transform treatment of deadly cerebral malaria
Master’s student Taznita Kista is exploring whether a nano-enabled nasal spray could change how cerebral malaria is treated. Her work focuses on a nose-to-brain drug delivery system using niosomes.